Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
- Conditions
- Catheter-Related Infections
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- Leonard-Meron Biosciences, Inc.
- Registration Number
- NCT04513821
- Locations
- 🇺🇸
Phoenix VA Health Care System, Phoenix, Arizona, United States
🇺🇸Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸Georgetown University Hospital, Washington, District of Columbia, United States
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
- First Posted Date
- 2016-09-15
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Leonard-Meron Biosciences, Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT02901717
- Locations
- 🇺🇸
Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸University of Florida Shands Hospital, Gainesville, Florida, United States
🇺🇸Edward Hines Jr. VA Hospital, Hines, Illinois, United States
News
No news found